Biden administration to release flu medicine from national stockpile

[ad_1]

The Biden administration said Wednesday it will release doses of prescription flu medicine from the Strategic National Stockpile to states as flu-sickened patients continue to flock to hospitals and doctors’ offices around the country.

This year’s flu season has hit hard and early. Some people are even noticing bare shelves at pharmacies and grocery stores when they make a run for over-the-counter medicines as cases have spiked. The Centers for Disease Control and Prevention estimates that the flu has resulted in 150,000 hospitalizations and 9,300 deaths so far this season.

“Jurisdictions will be able to get the support they need to keep Americans healthy as flu cases rise this winter,” Dawn O’Connell, an assistant secretary for preparedness and response at the Health and Human Services Department, which oversees the CDC, said in a statement.

States will be able to request doses of the prescription flu medication Tamiflu kept in the Strategic National Stockpile from HHS. The administration is not releasing how many doses will be made available.

Last week, HHS also announced it would allow states to dip into statewide stockpiles for Tamiflu, making millions of treatment courses available. Tamiflu can be prescribed to treat flu in people over the age of 2 weeks old.

Not a Modern Healthcare subscriber? Sign up today.

This flu season is coming on the heels of a nasty spike of RSV, or respiratory syncytial virus, cases in children and just as COVID-19 cases are climbing — again.

Spot shortages of over-the-counter pain relievers and medicines have been reported at stores around the country, particularly for children.

CVS Health, for example, has placed a two-product limit on all children’s pain relief products bought through its pharmacies or online. Walgreens is limiting customers online to six purchases of children’s over-the-counter fever reducing products.

The Food and Drug Administration has not reported a shortage of Tamiflu. However, the federal agency says the prescription antibiotic amoxicillin is in short supply due to increased demand.

Download Modern Healthcare’s app to stay informed when industry news breaks.

[ad_2]

Source link

Related Posts

Is it time to end 340B? – Healthcare Economist

[ad_1] A Health Affiairs Forefront article by DiGiorgio (2023) argues the 340B has outlived its purposes. He writes:  By mandating that drug…

A state-by-state look at the impact of Medicaid determinations

[ad_1] For Medicaid insurers, the looming loss of coverage threatens a financial shock. An estimated 15 million of the 91 million people with Medicaid—or 16.5%—are expected to…

General Catalyst launches at-home startup amid economic uncertainty

[ad_1] General Catalyst is launching a digital health startup with a $25 million investment, betting that demand for at-home care outweighs the challenging macroeconomic environment.  The startup,…

In the era of public health threats, CDC modernization is a race against the clock

[ad_1] In the wake of the COVID-19 pandemic and widespread criticism of the response from the Centers for Disease Control and Prevention, Director Rochelle Walensky has called…

Connecticut-based Covenant Health terminates merger with Day Kimball

[ad_1] PUTNAM, Conn. — A Catholic-run healthcare system has withdrawn its application to affiliate with Day Kimball Healthcare, an independent, financially struggling hospital and healthcare system in…

Google tackles Medicaid redeterminations by updating search algorithm

[ad_1] Google is helping people navigate Medicaid redeterminations with the latest update to its search algorithm, the tech giant said Tuesday morning.  Google announced several new healthcare initiatives…

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: